By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

SRI International 

333 Ravenswood Avenue

Menlo Park  California  94025  U.S.A.
Phone: 866-451-5998 Fax: 650-859-2889


SEARCH JOBS

SRI International’s Biosciences Division carries out basic research, drug discovery and drug development, and provides contract services. SRI Biosciences has all of the resources necessary to take R&D from Idea to IND and Beyond™ —from initial discovery to human clinical trials—and specializes in cancer, immunology and inflammation, infectious disease, and neuroscience. SRI’s product pipeline has yielded marketed drugs, therapeutics currently in clinical trials, and additional programs in earlier stages. In its CRO business, SRI has helped government and other clients and partners advance well over 100 drugs into patient testing. SRI is also working to create the next generation of technologies in areas such as diagnostics, drug delivery, medical devices, and systems biology.


Key Statistics


Email: biosciences@sri.com
Ownership: Private

Web Site: SRI International
Employees: n/a
Symbol: 
 









Company News
SRI International Names Luther Lau Chief Financial Officer 12/16/2014 7:53:47 AM
Peter Kant Joins SRI International As Executive Director Of SRI's Center For Science, Technology, And Economic Development 12/8/2014 8:39:01 AM
SRI International's BioCyc Database Collection Expanded For Easy Access To Information About Microbes And Metabolic Pathways 11/10/2014 10:42:33 AM
SRI International Opens Clinical Trial Unit In Michigan Life Science Innovation Center 10/21/2014 9:21:22 AM
SRI International Selects Michael Page As Vice President Of Information Technology Services And Chief Information Officer 10/7/2014 8:37:55 AM
SRI International Honors Gregory Faris And Jon Mirsalis With 2014 Fellows Awards 10/2/2014 12:02:44 PM
SRI International And Nobelpharma, Partner On Endometriosis Drug Development 9/9/2014 11:01:21 AM
National Institutes of Health (NIH) Awards SRI International A $49 Million Contract To Study New Therapies For HIV And AIDS 7/25/2014 9:18:42 AM
William Jeffrey Joins SRI International As President And CEO 6/25/2014 10:23:48 AM
Defense Advanced Research Projects Agency Funds George Washington University; SRI International; Protea Biosciences, Inc. ; And GE Global Research Are Partners 1/28/2014 9:05:47 AM
12345678910...
//-->